ZIMMER BIOMET HLDGS DL-01ZIMMER BIOMET HLDGS DL-01ZIMMER BIOMET HLDGS DL-01

ZIMMER BIOMET HLDGS DL-01

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪20.54 B‬EUR
4.75EUR
‪927.75 M‬EUR
‪6.70 B‬EUR
‪198.79 M‬
Beta (1Y)
0.49
Employees (FY)
‪18 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪372.18 K‬EUR
Net income / Employee (1Y)
‪51.54 K‬EUR

About Zimmer Biomet Holdings, Inc.


CEO
Ivan Tornos
Headquarters
Warsaw
Founded
1927
FIGI
BBG000CSMP13
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ZIMF
ZIMMER BIOMET HLDGS 15/45
Yield to maturity
6.23%
Maturity date
Aug 15, 2045
ZIME
ZIMMER BIOMET HLDGS 15/25
Yield to maturity
6.08%
Maturity date
Apr 1, 2025
ZIMC
ZIMMER BIOMET HLDGS 15/35
Yield to maturity
5.89%
Maturity date
Aug 15, 2035
ZBH3676776
Zimmer Biomet Holdings, Inc. 5.75% 30-NOV-2039
Yield to maturity
5.58%
Maturity date
Nov 30, 2039
ZBH5302814
Zimmer Biomet Holdings, Inc. 2.6% 24-NOV-2031
Yield to maturity
5.55%
Maturity date
Nov 24, 2031
ZBH5869685
Zimmer Biomet Holdings, Inc. 5.2% 15-SEP-2034
Yield to maturity
5.50%
Maturity date
Sep 15, 2034
ZBH4966995
Zimmer Biomet Holdings, Inc. 3.55% 20-MAR-2030
Yield to maturity
5.31%
Maturity date
Mar 20, 2030
ZBH5710697
Zimmer Biomet Holdings, Inc. 5.35% 01-DEC-2028
Yield to maturity
4.94%
Maturity date
Dec 1, 2028
ZBH4966994
Zimmer Biomet Holdings, Inc. 3.05% 15-JAN-2026
Yield to maturity
4.83%
Maturity date
Jan 15, 2026
XS287510616
ZIMMER BIOM. 24/32
Yield to maturity
3.44%
Maturity date
Dec 15, 2032
XS207910589
ZIMMER BIOM. 19/27
Yield to maturity
2.84%
Maturity date
Nov 15, 2027

Explore more bonds 

Frequently Asked Questions


The current price of ZIM is 102.50 EUR — it has increased by 1.03% in the past 24 hours. Watch ZIMMER BIOMET HLDGS DL-01 stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ZIMMER BIOMET HLDGS DL-01 stocks are traded under the ticker ZIM.
ZIM stock has risen by 0.94% compared to the previous week, the month change is a −2.80% fall, over the last year ZIMMER BIOMET HLDGS DL-01 has showed a −4.74% decrease.
We've gathered analysts' opinions on ZIMMER BIOMET HLDGS DL-01 future price: according to them, ZIM price has a max estimate of 134.60 EUR and a min estimate of 102.87 EUR. Watch ZIM chart and read a more detailed ZIMMER BIOMET HLDGS DL-01 stock forecast: see what analysts think of ZIMMER BIOMET HLDGS DL-01 and suggest that you do with its stocks.
ZIM reached its all-time high on Feb 17, 2020 with the price of 146.00 EUR, and its all-time low was 24.85 EUR and was reached on Mar 20, 2009. View more price dynamics on ZIM chart.
See other stocks reaching their highest and lowest prices.
ZIM stock is 1.02% volatile and has beta coefficient of 0.49. Track ZIMMER BIOMET HLDGS DL-01 stock price on the chart and check out the list of the most volatile stocks — is ZIMMER BIOMET HLDGS DL-01 there?
Today ZIMMER BIOMET HLDGS DL-01 has the market capitalization of ‪20.54 B‬, it has increased by 1.07% over the last week.
Yes, you can track ZIMMER BIOMET HLDGS DL-01 financials in yearly and quarterly reports right on TradingView.
ZIMMER BIOMET HLDGS DL-01 is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
ZIM earnings for the last quarter are 1.56 EUR per share, whereas the estimation was 1.57 EUR resulting in a −0.22% surprise. The estimated earnings for the next quarter are 2.21 EUR per share. See more details about ZIMMER BIOMET HLDGS DL-01 earnings.
ZIMMER BIOMET HLDGS DL-01 revenue for the last quarter amounts to ‪1.64 B‬ EUR, despite the estimated figure of ‪1.62 B‬ EUR. In the next quarter, revenue is expected to reach ‪1.94 B‬ EUR.
ZIM net income for the last quarter is ‪223.64 M‬ EUR, while the quarter before that showed ‪226.68 M‬ EUR of net income which accounts for −1.34% change. Track more ZIMMER BIOMET HLDGS DL-01 financial stats to get the full picture.
Yes, ZIM dividends are paid quarterly. The last dividend per share was 0.22 EUR. As of today, Dividend Yield (TTM)% is 0.89%. Tracking ZIMMER BIOMET HLDGS DL-01 dividends might help you take more informed decisions.
ZIMMER BIOMET HLDGS DL-01 dividend yield was 0.79% in 2023, and payout ratio reached 19.66%. The year before the numbers were 0.75% and 87.25% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 26, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is ZIMMER BIOMET HLDGS DL-01 on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ZIMMER BIOMET HLDGS DL-01 EBITDA is ‪2.17 B‬ EUR, and current EBITDA margin is 31.63%. See more stats in ZIMMER BIOMET HLDGS DL-01 financial statements.
Like other stocks, ZIM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ZIMMER BIOMET HLDGS DL-01 stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ZIMMER BIOMET HLDGS DL-01 technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ZIMMER BIOMET HLDGS DL-01 stock shows the sell signal. See more of ZIMMER BIOMET HLDGS DL-01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.